Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | B003 |
| Synonyms | |
| Therapy Description |
B003 is an antibody-drug conjugate (ADC) comprising a monoclonal ERBB2 (HER2) antibody linked to DM1, which delivers the anti-microtubule agent to ERBB2 (HER2)-overexpressing cells, potentially inducing cell cycle arrest and inhibiting proliferation of tumor cells overexpressing ERBB2 (HER2) (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| B003 | B 003|B-003|ADC B003|anti-HER2-DM1 ADC B003 | HER2 (ERBB2) Antibody 80 HER2 (ERBB2) Antibody-Drug Conjugate 36 | B003 is an antibody-drug conjugate (ADC) comprising a monoclonal ERBB2 (HER2) antibody linked to DM1, which delivers the anti-microtubule agent to ERBB2 (HER2)-overexpressing cells, potentially inducing cell cycle arrest and inhibiting proliferation of tumor cells overexpressing ERBB2 (HER2) (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|